• 1. Evidence-Based Medicine Center of Nantong University, Medical School of Nantong University, Nantong 226001, China;2. Xinglin School of Nantong University, Nantong 226001, China;
NI Hengjian, Email: nihengjian@ntu.edu.cn
Export PDF Favorites Scan Get Citation

Objective  To investigate the situation of supplemental drugs to the national essential medicines list (EML) in primary health care facilities.
Methods Supplemental essential medicine lists published by provincial governments around our country were identified. Characteristics of categories, names and quantities of the supplemental drugs were extracted and compared.
Results Supplemental lists issued by 13 provinces were included. The number of the supplemental drugs of four provinces including Jiangsu, Guangdong, Inner Mongolia and Shandong surpassed 200. All the included lists contained chemicals and traditional Chinese medicine, as well as nine categories mentioned in the EML. The frequency of 17 drugs in the supplemental lists was over 10. Specific paediatrics drugs and antitumor drugs were considered by several provinces.
Conclusion At present, EML cannot meet the requirements of the primary healthcare. Selection and amendment of EML may refer to the supplemental lists which reflect the demands of essential drugs in every area in our country.

Citation: GENG Jinsong,DONG Jiancheng,JIANG Kui,NI Hengjian,CHEN Yalan,WU Huiqun,ZHANG Chujie,BAO Yueqi. Supplemental Essential Medicine Lists for Primary Healthcare in China: An Evidence-Based Analysis. Chinese Journal of Evidence-Based Medicine, 2011, 11(1): 35-38. doi: 10.7507/1672-2531.20110007 Copy

  • Previous Article

    Investigation on the Awareness of and Training Needs for the National Essential Medicine (2009 version) in Medical Workers in Xinjiang Province
  • Next Article

    Evaluation on Effectiveness of PBL in Evidence-Based Medicine Teaching